(JPNJPA) UBS(Lux)Fund Solutions – - Ratings and Ratios
Japan Stocks, Equity Fund, Large Cap Stocks
Description: JPNJPA UBS(Lux)Fund Solutions –
The UBS(Lux)Fund Solutions – MSCI Japan UCITS ETF(JPY)A-dis CHF is an exchange-traded fund (ETF) that tracks the Morningstar Japan TME NR JPY index, providing investors with exposure to Japans large-cap blend equity market. As a Switzerland-originated ETF, it is listed on the Swiss exchange.
From a performance perspective, the ETF has shown relatively stable price movements, with its 20-day simple moving average (SMA20) at 48.23 and 50-day simple moving average (SMA50) at 46.95, indicating a potential bullish trend. The average true range (ATR) is 0.47, representing a 0.97% daily price fluctuation, which is relatively moderate.
Key performance indicators (KPIs) for this ETF include its tracking error, expense ratio, and dividend yield. Although not provided, typical KPIs for similar ETFs suggest a tracking error of around 0.1-0.3%, an expense ratio of approximately 0.2-0.5%, and a dividend yield of around 2-4%. The funds assets under management (AUM) stand at 110.62 billion CHF, indicating a substantial investor base and liquidity.
Investors should consider the ETFs underlying index, the Morningstar Japan TME NR JPY, which is designed to represent the Japanese equity markets performance. The ETFs JPY currency exposure and CHF-denominated shares may also introduce currency translation risks. Overall, this ETF appears to be a viable option for investors seeking diversified exposure to Japans large-cap equity market.
JPNJPA ETF Overview
| Market Cap in USD | 185,343m |
| Category | Japan Large-Cap Blend Equity |
| TER | 0.10% |
| IPO / Inception | 2001-10-30 |
JPNJPA ETF Ratings
| Growth Rating | 5.43 |
| Fundamental | 45.0% |
| Dividend Rating | 14.8 |
| Rel. Strength | -6.54 |
| Analysts | - |
| Fair Price Momentum | 44.45 CHF |
| Fair Price DCF | - |
JPNJPA Dividends
Currently no dividends paidJPNJPA Growth Ratios
| Growth Correlation 3m | 38.7% |
| Growth Correlation 12m | -15.5% |
| Growth Correlation 5y | -3.3% |
| CAGR 5y | 5.03% |
| CAGR/Max DD 5y | 0.17 |
| Sharpe Ratio 12m | 0.92 |
| Alpha | -18.49 |
| Beta | 0.916 |
| Volatility | 17.16% |
| Current Volume | 0.8k |
| Average Volume 20d | 0.4k |
| Stop Loss | 48.5 (-3.1%) |
As of August 10, 2025, the stock is trading at CHF 50.07 with a total of 799 shares traded.
Over the past week, the price has changed by +3.56%, over one month by +6.23%, over three months by +5.06% and over the past year by +13.56%.
No, based on ValueRay´s Fundamental Analyses, UBS(Lux)Fund Solutions – (SW:JPNJPA) is currently (August 2025) a stock to sell. It has a ValueRay Fundamental Rating of 45.00 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JPNJPA is around 44.45 CHF . This means that JPNJPA is currently overvalued and has a potential downside of -11.22%.
UBS(Lux)Fund Solutions – has no consensus analysts rating.
According to our own proprietary Forecast Model, JPNJPA UBS(Lux)Fund Solutions – will be worth about 49.8 in August 2026. The stock is currently trading at 50.07. This means that the stock has a potential downside of -0.54%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 49.8 | -0.5% |
ValueRay Score 45.00
| 1. Piotroski 0.0pt = -5.0 |
JPNJPA Fundamental Data Overview
Market Cap CHF = 149.46b (149.46b CHF * 1.0 CHF.CHF)
[93m CCE Cash And Equivalents = unknown
[39m[93m Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 CHF
[39m Beta = 0.0
Revenue TTM = 0.0 CHF
EBIT TTM = 0.0 CHF
EBITDA TTM = 0.0 CHF
[93m Long Term Debt = unknown (none)
[39m[93m Short Term Debt = unknown (none)
[39m[93m Debt = unknown
[39m[93m Net Debt = unknown
[39m Enterprise Value = 149.46b CHF (149.46b + (null Debt) - (null CCE))
[93m Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
[39m[93m FCF Yield = none (FCF TTM 0.0 / Enterprise Value 149.46b)
[39m[93m FCF Margin = unknown (Revenue TTM is 0)
[39m[93m Net Margin = unknown
[39m[93m Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
[39m[93m Tobins Q-Ratio = unknown (Enterprise Value 149.46b / Book Value Of Equity 0.0)
[39m Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
[93m Taxrate = unknown
[39m[93m NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
[39m[93m Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
[39m[93m Debt / Equity = unknown Debt (none)
[39m[93m Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
[39m[93m Debt / FCF = none (Debt none / FCF TTM 0.0)
[39m[93m Total Stockholder Equity = unknown
[39m[93m RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
[39m[93m RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
[39m[93m RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
[39m[93m WACC = unknown (E(149.46b)/V(0.0) * Re(9.39%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
[39m Discount Rate = 9.39% (= CAPM, Blume Beta Adj.)
[93m Fair Price DCF = unknown (Cash Flow 0.0)
[39m